TPH1 and obesity due to melanocortin 4 receptor deficiency: Significantly elevated mucosal TPH1 expression in obese humans (38, 39) and elevated levels of circulating 5-HT in individuals with type 2 diabetes (T2D) (40–42) or obesity (38) has been reported.